Short‐course versus long‐course intravenous therapy with the same antibiotic for severe community‐acquired pneumonia in children aged two months to 59 months

Read the full review here

Authors identified no randomised controlled trials comparing a short course (two to three days) of intravenous antibiotics compared to a long course (five days) for severe pneumonia in children aged two months to 59 months that met the inclusion criteria.

The WHO recommends intravenous antibiotics for five days as first-line treatment for children with severe pneumonia. This review aims to evaluate the efficacy of short-course versus long-course intravenous therapy (alone or in combination with oral antibiotics) with the same antibiotic for severe community-acquired pneumonia in children aged two months to 59 months

Add yours ↓

Comments are closed.